

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.11556080 |
| 2 | presynaptic membrane organization (GO:0097090) | 5.08931566 |
| 3 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.94540818 |
| 4 | presynaptic membrane assembly (GO:0097105) | 4.75057017 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.73078712 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.70855801 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.63758280 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.60606656 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.58264112 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.58264112 |
| 11 | glutamate secretion (GO:0014047) | 4.46123358 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.39734880 |
| 13 | locomotory exploration behavior (GO:0035641) | 4.35809887 |
| 14 | vocalization behavior (GO:0071625) | 4.35526303 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.31887035 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.31617282 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.30760324 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25999708 |
| 19 | protein localization to synapse (GO:0035418) | 4.22304489 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.07200832 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.05354680 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.01744865 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.97851449 |
| 24 | neuronal action potential propagation (GO:0019227) | 3.96728097 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.92774197 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.92406170 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.89190982 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.88914048 |
| 29 | neurotransmitter secretion (GO:0007269) | 3.86996638 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.78374617 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.75884526 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.75884526 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 3.75884526 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.75884526 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.75884526 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.75884526 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.69133467 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.64814690 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.63387429 |
| 40 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58583825 |
| 41 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.55327869 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 3.53331030 |
| 43 | postsynaptic membrane organization (GO:0001941) | 3.52309659 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.46730689 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.42824229 |
| 46 | mannose metabolic process (GO:0006013) | 3.41429117 |
| 47 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.41236338 |
| 48 | proline transport (GO:0015824) | 3.38645462 |
| 49 | exploration behavior (GO:0035640) | 3.37741988 |
| 50 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.34943187 |
| 51 | layer formation in cerebral cortex (GO:0021819) | 3.25480072 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.24462497 |
| 53 | regulation of vesicle fusion (GO:0031338) | 3.20759750 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.20429194 |
| 55 | positive regulation of synapse maturation (GO:0090129) | 3.18563588 |
| 56 | cellular potassium ion homeostasis (GO:0030007) | 3.18532048 |
| 57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.18175811 |
| 58 | regulation of synapse structural plasticity (GO:0051823) | 3.17227121 |
| 59 | neurotransmitter transport (GO:0006836) | 3.14805544 |
| 60 | long-term memory (GO:0007616) | 3.13328495 |
| 61 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.13285135 |
| 62 | nerve growth factor signaling pathway (GO:0038180) | 3.11456003 |
| 63 | macrophage activation involved in immune response (GO:0002281) | 3.11179980 |
| 64 | gamma-aminobutyric acid transport (GO:0015812) | 3.08728101 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.07577758 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 3.07530355 |
| 67 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.07111778 |
| 68 | membrane depolarization during action potential (GO:0086010) | 3.06143558 |
| 69 | detection of other organism (GO:0098543) | 3.05749009 |
| 70 | detection of bacterium (GO:0016045) | 3.04945834 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 3.04937817 |
| 72 | neuron recognition (GO:0008038) | 3.02514759 |
| 73 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02504673 |
| 74 | long-term synaptic potentiation (GO:0060291) | 3.02475126 |
| 75 | membrane hyperpolarization (GO:0060081) | 3.01277797 |
| 76 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.00027191 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.99765654 |
| 78 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.97060116 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 2.92930228 |
| 80 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.91518555 |
| 81 | regulation of neurotransmitter transport (GO:0051588) | 2.91481442 |
| 82 | membrane depolarization (GO:0051899) | 2.91183269 |
| 83 | glycine transport (GO:0015816) | 2.90277685 |
| 84 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.88690764 |
| 85 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.88613708 |
| 86 | regulation of synaptic plasticity (GO:0048167) | 2.88307679 |
| 87 | leukocyte aggregation (GO:0070486) | 2.88195772 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87896131 |
| 89 | regulation of neurotransmitter levels (GO:0001505) | 2.87305726 |
| 90 | regulation of regulated secretory pathway (GO:1903305) | 2.86838428 |
| 91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.85250574 |
| 92 | regulation of ARF GTPase activity (GO:0032312) | 2.84447201 |
| 93 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83180493 |
| 94 | transmission of nerve impulse (GO:0019226) | 2.82602741 |
| 95 | positive regulation of synapse assembly (GO:0051965) | 2.81339536 |
| 96 | regulation of exocytosis (GO:0017157) | 2.80720648 |
| 97 | cell migration in hindbrain (GO:0021535) | 2.79424477 |
| 98 | regulation of synapse maturation (GO:0090128) | 2.79266902 |
| 99 | response to peptidoglycan (GO:0032494) | 2.78133184 |
| 100 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.77917836 |
| 101 | germinal center formation (GO:0002467) | 2.76969745 |
| 102 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.76260845 |
| 103 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76176639 |
| 104 | regulation of ARF protein signal transduction (GO:0032012) | 2.74558160 |
| 105 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.73867901 |
| 106 | regulation of gamma-delta T cell activation (GO:0046643) | 2.73701042 |
| 107 | synapse assembly (GO:0007416) | 2.73095955 |
| 108 | response to pheromone (GO:0019236) | 2.72784197 |
| 109 | dendritic spine morphogenesis (GO:0060997) | 2.72739110 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 2.72618124 |
| 111 | innervation (GO:0060384) | 2.71280988 |
| 112 | cerebellar granule cell differentiation (GO:0021707) | 2.71195816 |
| 113 | dendrite morphogenesis (GO:0048813) | 2.70986808 |
| 114 | positive regulation of exocytosis (GO:0045921) | 2.70579748 |
| 115 | activation of protein kinase A activity (GO:0034199) | 2.70263599 |
| 116 | protein localization to endosome (GO:0036010) | 2.68929801 |
| 117 | neuronal action potential (GO:0019228) | 2.67600516 |
| 118 | neuronal ion channel clustering (GO:0045161) | 2.67584817 |
| 119 | negative regulation of interleukin-12 production (GO:0032695) | 2.65939199 |
| 120 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.65864031 |
| 121 | axonal fasciculation (GO:0007413) | 2.65649703 |
| 122 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.64596208 |
| 123 | regulation of defense response to virus by virus (GO:0050690) | 2.63185446 |
| 124 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.62244925 |
| 125 | neuromuscular synaptic transmission (GO:0007274) | 2.62142544 |
| 126 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.60054313 |
| 127 | mechanosensory behavior (GO:0007638) | 2.60049253 |
| 128 | B cell receptor signaling pathway (GO:0050853) | 2.59511306 |
| 129 | mating behavior (GO:0007617) | 2.58007656 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.57619339 |
| 131 | cellular response to type I interferon (GO:0071357) | 2.57619339 |
| 132 | neuromuscular process controlling balance (GO:0050885) | 2.57073481 |
| 133 | regulation of leukocyte degranulation (GO:0043300) | 2.56901435 |
| 134 | regulation of synaptic transmission (GO:0050804) | 2.56329003 |
| 135 | positive regulation of vesicle fusion (GO:0031340) | 2.56328061 |
| 136 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.56017488 |
| 137 | synaptic vesicle transport (GO:0048489) | 2.55846958 |
| 138 | establishment of synaptic vesicle localization (GO:0097480) | 2.55846958 |
| 139 | response to host immune response (GO:0052572) | 2.55419055 |
| 140 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55419055 |
| 141 | synaptic transmission (GO:0007268) | 2.55184352 |
| 142 | startle response (GO:0001964) | 2.54804593 |
| 143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.54237207 |
| 144 | response to type I interferon (GO:0034340) | 2.53447980 |
| 145 | positive thymic T cell selection (GO:0045059) | 2.50781110 |
| 146 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50107071 |
| 147 | signal complex assembly (GO:0007172) | 2.48552027 |
| 148 | COPI coating of Golgi vesicle (GO:0048205) | 2.48363266 |
| 149 | Golgi transport vesicle coating (GO:0048200) | 2.48363266 |
| 150 | respiratory burst (GO:0045730) | 2.47141671 |
| 151 | regulation of mast cell degranulation (GO:0043304) | 2.46781933 |
| 152 | positive regulation of Rap GTPase activity (GO:0032854) | 2.45944945 |
| 153 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.45671497 |
| 154 | detection of external biotic stimulus (GO:0098581) | 2.44789987 |
| 155 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.44413062 |
| 156 | negative regulation of glial cell proliferation (GO:0060253) | 2.44405547 |
| 157 | regulation of cellular amide metabolic process (GO:0034248) | 2.43769101 |
| 158 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.41679163 |
| 159 | activation of MAPKKK activity (GO:0000185) | 2.41558418 |
| 160 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.38826743 |
| 161 | thymic T cell selection (GO:0045061) | 2.36801695 |
| 162 | establishment of mitochondrion localization (GO:0051654) | 2.35826938 |
| 163 | positive regulation of regulated secretory pathway (GO:1903307) | 2.35455996 |
| 164 | negative thymic T cell selection (GO:0045060) | 2.35307125 |
| 165 | response to host (GO:0075136) | 2.34588065 |
| 166 | response to host defenses (GO:0052200) | 2.34588065 |
| 167 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.34588065 |
| 168 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.34532801 |
| 169 | negative regulation of type 2 immune response (GO:0002829) | 2.34381077 |
| 170 | amino acid import (GO:0043090) | 2.33423363 |
| 171 | negative regulation of cell size (GO:0045792) | 2.32789623 |
| 172 | barbed-end actin filament capping (GO:0051016) | 2.31887405 |
| 173 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.30179828 |
| 174 | T cell selection (GO:0045058) | 2.28632000 |
| 175 | glucose 6-phosphate metabolic process (GO:0051156) | 2.26331320 |
| 176 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.25933867 |
| 177 | negative T cell selection (GO:0043383) | 2.24417997 |
| 178 | positive T cell selection (GO:0043368) | 2.23988082 |
| 179 | response to laminar fluid shear stress (GO:0034616) | 2.23281444 |
| 180 | negative regulation of T cell mediated immunity (GO:0002710) | 2.20897644 |
| 181 | L-amino acid import (GO:0043092) | 2.20838335 |
| 182 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.19047735 |
| 183 | actin filament polymerization (GO:0030041) | 2.18922841 |
| 184 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.18081468 |
| 185 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.17125438 |
| 186 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.12892012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.71825009 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54098613 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.16271904 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.99122353 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.84936066 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.75230328 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.69701011 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69677897 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.57831635 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.56173688 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54025563 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.47478082 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.40028508 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.39344614 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33786380 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31163677 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30880128 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.30088538 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.25692704 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25420634 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19195337 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19145306 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.18155986 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.18155986 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11114192 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08132861 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.07210686 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06844208 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06782688 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05933219 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05869315 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04260245 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.03585647 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.99800993 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98426937 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95081224 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.93433545 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.92375063 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85810713 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85046171 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.83566126 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.83434267 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81470497 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79519458 |
| 45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79315768 |
| 46 | * P68_20966046_ChIP-Seq_HELA_Human | 1.78875063 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77498691 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74975035 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.74736867 |
| 50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.71432389 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.71315519 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.70994880 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.69556096 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69210183 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68386313 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.68018036 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.66935631 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.66270069 |
| 59 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.66113941 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65510914 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63445126 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.62346918 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.61265932 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59102965 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57277654 |
| 66 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56083634 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55938330 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54907196 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.53450280 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53014393 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52575189 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52285569 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51821821 |
| 74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.51266759 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50904894 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49816660 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47751740 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46168788 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44342091 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42660212 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42208580 |
| 82 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41901000 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40783807 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39200196 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38638862 |
| 86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.36158900 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35454918 |
| 88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33554887 |
| 89 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32511227 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31601197 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30835331 |
| 92 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30473928 |
| 93 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28848407 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26564790 |
| 95 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26442771 |
| 96 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25445572 |
| 97 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24920349 |
| 98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24773005 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23712544 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23399985 |
| 101 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22689748 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22262119 |
| 103 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20972907 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20956457 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20216287 |
| 106 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19950302 |
| 107 | SA1_27219007_Chip-Seq_Bcells_Human | 1.18885481 |
| 108 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18765755 |
| 109 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17963634 |
| 110 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17935098 |
| 111 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17307954 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17132663 |
| 113 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16827181 |
| 114 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15467894 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14618839 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14384131 |
| 117 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.13436787 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13387980 |
| 119 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.12728686 |
| 120 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12552718 |
| 121 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12079993 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11956588 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10265646 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09768874 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09534784 |
| 126 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09309383 |
| 127 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.09069102 |
| 128 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08498984 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08348937 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07168791 |
| 131 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06995893 |
| 132 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06850415 |
| 133 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06478650 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05978932 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05482700 |
| 136 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05076340 |
| 137 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05051835 |
| 138 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05008810 |
| 139 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.04986307 |
| 140 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04568849 |
| 141 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04061090 |
| 142 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03827559 |
| 143 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03574962 |
| 144 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03340618 |
| 145 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03333018 |
| 146 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.02442266 |
| 147 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02311410 |
| 148 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02235693 |
| 149 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.02118712 |
| 150 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02111460 |
| 151 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01962604 |
| 152 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01650396 |
| 153 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01380043 |
| 154 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01159250 |
| 155 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00190066 |
| 156 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99873304 |
| 157 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99702988 |
| 158 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99653290 |
| 159 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99096662 |
| 160 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97654218 |
| 161 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96723757 |
| 162 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95080469 |
| 163 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94310706 |
| 164 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94098874 |
| 165 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94096235 |
| 166 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93462595 |
| 167 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93165166 |
| 168 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92878159 |
| 169 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92420410 |
| 170 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92369709 |
| 171 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91947990 |
| 172 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91275058 |
| 173 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91199066 |
| 174 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90894287 |
| 175 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90840236 |
| 176 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90840236 |
| 177 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90281698 |
| 178 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88672268 |
| 179 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88493928 |
| 180 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88356789 |
| 181 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87975197 |
| 182 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86270645 |
| 183 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85136743 |
| 184 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85106037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.16089511 |
| 2 | MP0003880_abnormal_central_pattern | 3.89870263 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.69321871 |
| 4 | MP0008260_abnormal_autophagy | 3.66750269 |
| 5 | MP0003436_decreased_susceptibility_to | 3.53997481 |
| 6 | MP0004270_analgesia | 3.36569384 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.10674294 |
| 8 | MP0002735_abnormal_chemical_nociception | 3.04993832 |
| 9 | MP0009745_abnormal_behavioral_response | 3.01690091 |
| 10 | MP0005451_abnormal_body_composition | 2.89309478 |
| 11 | MP0009046_muscle_twitch | 2.88371014 |
| 12 | MP0002064_seizures | 2.86223111 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.83693229 |
| 14 | MP0003724_increased_susceptibility_to | 2.60593504 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.58512272 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.48131069 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.47902394 |
| 18 | MP0002272_abnormal_nervous_system | 2.46988321 |
| 19 | MP0009840_abnormal_foam_cell | 2.46847221 |
| 20 | MP0002736_abnormal_nociception_after | 2.44959125 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.44659724 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.44158295 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.33758275 |
| 24 | MP0001486_abnormal_startle_reflex | 2.23017432 |
| 25 | MP0001970_abnormal_pain_threshold | 2.08152994 |
| 26 | MP0002067_abnormal_sensory_capabilities | 2.06971246 |
| 27 | MP0008569_lethality_at_weaning | 2.03646058 |
| 28 | MP0005025_abnormal_response_to | 2.01251916 |
| 29 | MP0002419_abnormal_innate_immunity | 2.00924175 |
| 30 | MP0005646_abnormal_pituitary_gland | 2.00661626 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.99806369 |
| 32 | MP0005387_immune_system_phenotype | 1.94378959 |
| 33 | MP0001790_abnormal_immune_system | 1.94378959 |
| 34 | MP0009278_abnormal_bone_marrow | 1.93669711 |
| 35 | MP0002822_catalepsy | 1.91193735 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.91060046 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.90434859 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.89824315 |
| 39 | MP0004858_abnormal_nervous_system | 1.89606028 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.88879595 |
| 41 | MP0003787_abnormal_imprinting | 1.87955432 |
| 42 | MP0004947_skin_inflammation | 1.86853667 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.86174276 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.83841451 |
| 45 | MP0000685_abnormal_immune_system | 1.81992130 |
| 46 | MP0003329_amyloid_beta_deposits | 1.81502818 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.81240267 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.79351710 |
| 49 | MP0001800_abnormal_humoral_immune | 1.76858510 |
| 50 | MP0001835_abnormal_antigen_presentation | 1.75995587 |
| 51 | MP0002184_abnormal_innervation | 1.74332472 |
| 52 | MP0005671_abnormal_response_to | 1.72003220 |
| 53 | MP0001188_hyperpigmentation | 1.70654333 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.69361612 |
| 55 | MP0002723_abnormal_immune_serum | 1.68823160 |
| 56 | MP0009785_altered_susceptibility_to | 1.67118143 |
| 57 | MP0001984_abnormal_olfaction | 1.65407897 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.64295488 |
| 59 | MP0004924_abnormal_behavior | 1.64295488 |
| 60 | MP0000778_abnormal_nervous_system | 1.62604779 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.59128562 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.58849274 |
| 63 | MP0001819_abnormal_immune_cell | 1.58574843 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.57969006 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.56274048 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.54848699 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.54051408 |
| 68 | MP0004885_abnormal_endolymph | 1.53595208 |
| 69 | MP0002452_abnormal_antigen_presenting | 1.52994827 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 1.51524880 |
| 71 | MP0003866_abnormal_defecation | 1.50777385 |
| 72 | MP0003879_abnormal_hair_cell | 1.49773454 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.46253471 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.46231430 |
| 75 | MP0000955_abnormal_spinal_cord | 1.44559087 |
| 76 | MP0001986_abnormal_taste_sensitivity | 1.44238121 |
| 77 | MP0003633_abnormal_nervous_system | 1.43464943 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.43181004 |
| 79 | MP0002882_abnormal_neuron_morphology | 1.42228391 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.37728249 |
| 81 | MP0003075_altered_response_to | 1.34712874 |
| 82 | MP0010386_abnormal_urinary_bladder | 1.32992423 |
| 83 | MP0004510_myositis | 1.28450577 |
| 84 | MP0002229_neurodegeneration | 1.27635418 |
| 85 | MP0000716_abnormal_immune_system | 1.26195357 |
| 86 | MP0001545_abnormal_hematopoietic_system | 1.25502779 |
| 87 | MP0005397_hematopoietic_system_phenotyp | 1.25502779 |
| 88 | MP0004742_abnormal_vestibular_system | 1.24450071 |
| 89 | MP0005464_abnormal_platelet_physiology | 1.23354890 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.22945547 |
| 91 | MP0002398_abnormal_bone_marrow | 1.20915913 |
| 92 | MP0006082_CNS_inflammation | 1.20695885 |
| 93 | MP0003123_paternal_imprinting | 1.19540497 |
| 94 | MP0000858_altered_metastatic_potential | 1.18176727 |
| 95 | MP0003631_nervous_system_phenotype | 1.17277853 |
| 96 | MP0002405_respiratory_system_inflammati | 1.17125761 |
| 97 | MP0001905_abnormal_dopamine_level | 1.16780073 |
| 98 | MP0002876_abnormal_thyroid_physiology | 1.15755846 |
| 99 | MP0002132_abnormal_respiratory_system | 1.15562931 |
| 100 | MP0002638_abnormal_pupillary_reflex | 1.12948790 |
| 101 | MP0001845_abnormal_inflammatory_respons | 1.12516769 |
| 102 | MP0001529_abnormal_vocalization | 1.10442064 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 1.10054933 |
| 104 | MP0003303_peritoneal_inflammation | 1.07976194 |
| 105 | MP0002148_abnormal_hypersensitivity_rea | 1.06671255 |
| 106 | MP0003634_abnormal_glial_cell | 1.04868467 |
| 107 | MP0001849_ear_inflammation | 1.04446289 |
| 108 | MP0000920_abnormal_myelination | 1.01478321 |
| 109 | MP0004142_abnormal_muscle_tone | 1.00872508 |
| 110 | MP0005409_darkened_coat_color | 1.00153102 |
| 111 | MP0002429_abnormal_blood_cell | 0.99656768 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.98929254 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.97444725 |
| 114 | MP0004130_abnormal_muscle_cell | 0.96728463 |
| 115 | MP0002722_abnormal_immune_system | 0.95512400 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.95330906 |
| 117 | MP0008874_decreased_physiological_sensi | 0.94260603 |
| 118 | MP0002152_abnormal_brain_morphology | 0.92949289 |
| 119 | MP0005166_decreased_susceptibility_to | 0.90940422 |
| 120 | MP0008469_abnormal_protein_level | 0.90544046 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.89810877 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.88730405 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.88618727 |
| 124 | MP0000703_abnormal_thymus_morphology | 0.86787122 |
| 125 | MP0000689_abnormal_spleen_morphology | 0.86246317 |
| 126 | MP0001963_abnormal_hearing_physiology | 0.85000014 |
| 127 | MP0003632_abnormal_nervous_system | 0.84467692 |
| 128 | MP0005535_abnormal_body_temperature | 0.83156571 |
| 129 | MP0002090_abnormal_vision | 0.82830094 |
| 130 | MP0001664_abnormal_digestion | 0.81485115 |
| 131 | MP0002752_abnormal_somatic_nervous | 0.80533270 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.80199371 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79276723 |
| 134 | MP0000490_abnormal_crypts_of | 0.78985542 |
| 135 | MP0000465_gastrointestinal_hemorrhage | 0.78103232 |
| 136 | MP0000604_amyloidosis | 0.77494927 |
| 137 | MP0005253_abnormal_eye_physiology | 0.76375175 |
| 138 | MP0010234_abnormal_vibrissa_follicle | 0.75751285 |
| 139 | MP0003690_abnormal_glial_cell | 0.74564818 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.73141103 |
| 141 | MP0002933_joint_inflammation | 0.72325644 |
| 142 | MP0005310_abnormal_salivary_gland | 0.71942170 |
| 143 | MP0000631_abnormal_neuroendocrine_gland | 0.71789831 |
| 144 | MP0009764_decreased_sensitivity_to | 0.70399374 |
| 145 | MP0000681_abnormal_thyroid_gland | 0.69182363 |
| 146 | MP0003091_abnormal_cell_migration | 0.69113236 |
| 147 | MP0002751_abnormal_autonomic_nervous | 0.68450372 |
| 148 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68192616 |
| 149 | MP0001663_abnormal_digestive_system | 0.67652204 |
| 150 | MP0005499_abnormal_olfactory_system | 0.67474534 |
| 151 | MP0005394_taste/olfaction_phenotype | 0.67474534 |
| 152 | MP0008872_abnormal_physiological_respon | 0.66934245 |
| 153 | MP0005174_abnormal_tail_pigmentation | 0.66803544 |
| 154 | MP0001851_eye_inflammation | 0.66330158 |
| 155 | MP0004381_abnormal_hair_follicle | 0.65386308 |
| 156 | MP0000751_myopathy | 0.65211101 |
| 157 | MP0006072_abnormal_retinal_apoptosis | 0.64686595 |
| 158 | MP0001177_atelectasis | 0.64540647 |
| 159 | MP0004145_abnormal_muscle_electrophysio | 0.62107571 |
| 160 | MP0003122_maternal_imprinting | 0.61385192 |
| 161 | MP0000343_altered_response_to | 0.61383074 |
| 162 | MP0002928_abnormal_bile_duct | 0.60953763 |
| 163 | MP0003283_abnormal_digestive_organ | 0.60845197 |
| 164 | MP0004085_abnormal_heartbeat | 0.60463683 |
| 165 | MP0003868_abnormal_feces_composition | 0.55321168 |
| 166 | MP0003045_fibrosis | 0.54046478 |
| 167 | MP0001348_abnormal_lacrimal_gland | 0.53350979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.20205843 |
| 2 | Atonic seizures (HP:0010819) | 4.77576687 |
| 3 | Focal seizures (HP:0007359) | 4.71454794 |
| 4 | Myokymia (HP:0002411) | 4.68956821 |
| 5 | Febrile seizures (HP:0002373) | 4.63643270 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.63504922 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.32415849 |
| 8 | Visual hallucinations (HP:0002367) | 4.14294292 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.65931661 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.63562029 |
| 11 | Orchitis (HP:0100796) | 3.37116409 |
| 12 | Absence seizures (HP:0002121) | 3.31811525 |
| 13 | Myositis (HP:0100614) | 3.27615071 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.24653729 |
| 15 | Action tremor (HP:0002345) | 3.13402107 |
| 16 | Dialeptic seizures (HP:0011146) | 3.11826911 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.06253707 |
| 18 | * Ankle clonus (HP:0011448) | 3.04970824 |
| 19 | Scanning speech (HP:0002168) | 3.04353524 |
| 20 | Optic neuritis (HP:0100653) | 3.03906198 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.03906198 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.00278022 |
| 23 | Depression (HP:0000716) | 3.00192468 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 2.97311531 |
| 25 | Slow saccadic eye movements (HP:0000514) | 2.96875295 |
| 26 | Truncal ataxia (HP:0002078) | 2.92570185 |
| 27 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.89959040 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 2.89205266 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.88929819 |
| 30 | Gingivitis (HP:0000230) | 2.86770168 |
| 31 | Broad-based gait (HP:0002136) | 2.84399035 |
| 32 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.82019905 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.81588900 |
| 34 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.79198324 |
| 35 | Absent speech (HP:0001344) | 2.76628292 |
| 36 | Peripheral hypomyelination (HP:0007182) | 2.76322664 |
| 37 | Abnormality of the corticospinal tract (HP:0002492) | 2.73990202 |
| 38 | Insidious onset (HP:0003587) | 2.68090661 |
| 39 | Termporal pattern (HP:0011008) | 2.68090661 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.67796743 |
| 41 | * Spastic gait (HP:0002064) | 2.67697317 |
| 42 | Hyperventilation (HP:0002883) | 2.63933025 |
| 43 | Cellulitis (HP:0100658) | 2.61872491 |
| 44 | Failure to thrive in infancy (HP:0001531) | 2.61865424 |
| 45 | Limb dystonia (HP:0002451) | 2.60741532 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.60154048 |
| 47 | Papilledema (HP:0001085) | 2.57089019 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.55887685 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55887685 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55499600 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55499600 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55499600 |
| 53 | Genetic anticipation (HP:0003743) | 2.53374908 |
| 54 | Upper limb amyotrophy (HP:0009129) | 2.49907096 |
| 55 | Distal upper limb amyotrophy (HP:0007149) | 2.49907096 |
| 56 | Urinary urgency (HP:0000012) | 2.49060134 |
| 57 | Obstructive sleep apnea (HP:0002870) | 2.46797724 |
| 58 | Protruding tongue (HP:0010808) | 2.45733946 |
| 59 | Retinal dysplasia (HP:0007973) | 2.44028708 |
| 60 | Retinal atrophy (HP:0001105) | 2.43365139 |
| 61 | Meningitis (HP:0001287) | 2.41965689 |
| 62 | Loss of speech (HP:0002371) | 2.40239202 |
| 63 | Poor eye contact (HP:0000817) | 2.36977802 |
| 64 | Abnormality of the lower motor neuron (HP:0002366) | 2.36842265 |
| 65 | Pheochromocytoma (HP:0002666) | 2.36332055 |
| 66 | Inability to walk (HP:0002540) | 2.36256211 |
| 67 | Hand muscle atrophy (HP:0009130) | 2.35388649 |
| 68 | Epileptiform EEG discharges (HP:0011182) | 2.34868240 |
| 69 | Bradykinesia (HP:0002067) | 2.34600431 |
| 70 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.34351053 |
| 71 | Reticulocytosis (HP:0001923) | 2.33804463 |
| 72 | Dysmetria (HP:0001310) | 2.32841097 |
| 73 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.31966801 |
| 74 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.31966801 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29072417 |
| 76 | Obstructive lung disease (HP:0006536) | 2.29072417 |
| 77 | Impaired social interactions (HP:0000735) | 2.29013749 |
| 78 | Abnormal social behavior (HP:0012433) | 2.29013749 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.28844481 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28692011 |
| 81 | Anxiety (HP:0000739) | 2.28686328 |
| 82 | Hypoplasia of the brainstem (HP:0002365) | 2.28342898 |
| 83 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.28342898 |
| 84 | Increased IgE level (HP:0003212) | 2.27510665 |
| 85 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26672402 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 2.24988306 |
| 87 | Agitation (HP:0000713) | 2.24643448 |
| 88 | Hypothermia (HP:0002045) | 2.23526730 |
| 89 | Postural instability (HP:0002172) | 2.23239147 |
| 90 | Excessive salivation (HP:0003781) | 2.22836434 |
| 91 | Drooling (HP:0002307) | 2.22836434 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.21968788 |
| 93 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21620327 |
| 94 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21620327 |
| 95 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21620327 |
| 96 | Progressive inability to walk (HP:0002505) | 2.20606427 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.19905042 |
| 98 | Mutism (HP:0002300) | 2.19328747 |
| 99 | Recurrent fungal infections (HP:0002841) | 2.19327079 |
| 100 | Akinesia (HP:0002304) | 2.18850919 |
| 101 | Congenital stationary night blindness (HP:0007642) | 2.17458665 |
| 102 | Impaired smooth pursuit (HP:0007772) | 2.16980374 |
| 103 | Stereotypic behavior (HP:0000733) | 2.15637273 |
| 104 | Abnormal hair whorl (HP:0010721) | 2.15145076 |
| 105 | Amblyopia (HP:0000646) | 2.11874517 |
| 106 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.11131372 |
| 107 | Rapidly progressive (HP:0003678) | 2.09891666 |
| 108 | Apathy (HP:0000741) | 2.09872437 |
| 109 | Hypsarrhythmia (HP:0002521) | 2.09618643 |
| 110 | Neoplasm of the adrenal cortex (HP:0100641) | 2.07276520 |
| 111 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.07266174 |
| 112 | Colitis (HP:0002583) | 2.06717319 |
| 113 | Type II lissencephaly (HP:0007260) | 2.06586532 |
| 114 | Hemiplegia (HP:0002301) | 2.06131228 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 2.05798153 |
| 116 | Dysdiadochokinesis (HP:0002075) | 2.05780645 |
| 117 | Central scotoma (HP:0000603) | 2.05548998 |
| 118 | Gastrointestinal inflammation (HP:0004386) | 2.05232003 |
| 119 | Open mouth (HP:0000194) | 2.03216987 |
| 120 | Hypoventilation (HP:0002791) | 2.02696276 |
| 121 | Distal lower limb amyotrophy (HP:0008944) | 2.02465657 |
| 122 | Growth hormone excess (HP:0000845) | 2.02129930 |
| 123 | Gastrointestinal stroma tumor (HP:0100723) | 2.00821295 |
| 124 | Abnormality of macular pigmentation (HP:0008002) | 2.00577597 |
| 125 | Pulmonary infiltrates (HP:0002113) | 1.99609714 |
| 126 | Insomnia (HP:0100785) | 1.97910060 |
| 127 | Intention tremor (HP:0002080) | 1.97442682 |
| 128 | Difficulty climbing stairs (HP:0003551) | 1.97329800 |
| 129 | Tented upper lip vermilion (HP:0010804) | 1.97232472 |
| 130 | Recurrent skin infections (HP:0001581) | 1.96776960 |
| 131 | Cerebral inclusion bodies (HP:0100314) | 1.95946101 |
| 132 | Abnormality of binocular vision (HP:0011514) | 1.95436828 |
| 133 | Diplopia (HP:0000651) | 1.95436828 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.94312760 |
| 135 | Neurofibrillary tangles (HP:0002185) | 1.94022689 |
| 136 | Vasculitis (HP:0002633) | 1.94015347 |
| 137 | * Lower limb muscle weakness (HP:0007340) | 1.93364463 |
| 138 | Gastrointestinal infarctions (HP:0005244) | 1.92765338 |
| 139 | Malnutrition (HP:0004395) | 1.92282110 |
| 140 | Lower limb amyotrophy (HP:0007210) | 1.91964193 |
| 141 | Amyotrophic lateral sclerosis (HP:0007354) | 1.91604618 |
| 142 | Fetal akinesia sequence (HP:0001989) | 1.91239574 |
| 143 | Hyperacusis (HP:0010780) | 1.90864558 |
| 144 | Polyphagia (HP:0002591) | 1.90276547 |
| 145 | Exotropia (HP:0000577) | 1.90263863 |
| 146 | Inflammation of the large intestine (HP:0002037) | 1.90242613 |
| 147 | Upper motor neuron abnormality (HP:0002127) | 1.86782221 |
| 148 | Gait imbalance (HP:0002141) | 1.86075587 |
| 149 | Encephalitis (HP:0002383) | 1.85862670 |
| 150 | Amyloidosis (HP:0011034) | 1.85496278 |
| 151 | Anosmia (HP:0000458) | 1.84948902 |
| 152 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.84703836 |
| 153 | Abnormality of salivation (HP:0100755) | 1.84630454 |
| 154 | Hemiparesis (HP:0001269) | 1.83382871 |
| 155 | Emphysema (HP:0002097) | 1.83093320 |
| 156 | Increased serum ferritin (HP:0003281) | 1.82818584 |
| 157 | Neuroendocrine neoplasm (HP:0100634) | 1.82220461 |
| 158 | Cholecystitis (HP:0001082) | 1.81133896 |
| 159 | Abnormal gallbladder physiology (HP:0012438) | 1.81133896 |
| 160 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81094763 |
| 161 | Bradycardia (HP:0001662) | 1.80864796 |
| 162 | Rigidity (HP:0002063) | 1.80072555 |
| 163 | Panhypogammaglobulinemia (HP:0003139) | 1.79839595 |
| 164 | Prolonged bleeding time (HP:0003010) | 1.78998090 |
| 165 | Urticaria (HP:0001025) | 1.78365152 |
| 166 | Diminished motivation (HP:0000745) | 1.78210421 |
| 167 | Blue irides (HP:0000635) | 1.78134502 |
| 168 | Stomatitis (HP:0010280) | 1.78077043 |
| 169 | Progressive neurologic deterioration (HP:0002344) | 1.77069023 |
| 170 | Ventricular fibrillation (HP:0001663) | 1.75770589 |
| 171 | Iris hypopigmentation (HP:0007730) | 1.74632420 |
| 172 | Hemoptysis (HP:0002105) | 1.74438710 |
| 173 | Chest pain (HP:0100749) | 1.73428876 |
| 174 | Hyperparathyroidism (HP:0000843) | 1.73205270 |
| 175 | Ragged-red muscle fibers (HP:0003200) | 1.73135869 |
| 176 | Hypercortisolism (HP:0001578) | 1.72822759 |
| 177 | Premature loss of primary teeth (HP:0006323) | 1.72354645 |
| 178 | Petechiae (HP:0000967) | 1.71850224 |
| 179 | Systemic lupus erythematosus (HP:0002725) | 1.71736507 |
| 180 | Episodic fever (HP:0001954) | 1.71302291 |
| 181 | Keratoconjunctivitis (HP:0001096) | 1.70217566 |
| 182 | Ocular albinism (HP:0001107) | 1.69770375 |
| 183 | Deep palmar crease (HP:0006191) | 1.69625580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.74216855 |
| 2 | CASK | 3.46048660 |
| 3 | MARK1 | 3.05829705 |
| 4 | ERN1 | 2.98146214 |
| 5 | MAP3K9 | 2.95460232 |
| 6 | TRIB3 | 2.79720618 |
| 7 | DAPK2 | 2.67724594 |
| 8 | MAP3K4 | 2.60237269 |
| 9 | PRPF4B | 2.45080574 |
| 10 | MAP4K1 | 2.44793193 |
| 11 | EPHA4 | 2.39272794 |
| 12 | MINK1 | 2.27112693 |
| 13 | MAP2K7 | 2.23853918 |
| 14 | MAP3K11 | 2.16164350 |
| 15 | NTRK2 | 2.01872548 |
| 16 | NTRK1 | 1.85477494 |
| 17 | FES | 1.82700172 |
| 18 | PAK6 | 1.80887678 |
| 19 | TESK2 | 1.77718436 |
| 20 | ICK | 1.71028148 |
| 21 | TAOK1 | 1.68677737 |
| 22 | SIK2 | 1.66874724 |
| 23 | IRAK4 | 1.66831333 |
| 24 | SMG1 | 1.66451618 |
| 25 | TNIK | 1.66037875 |
| 26 | MAP3K6 | 1.65188159 |
| 27 | MAP2K3 | 1.64906201 |
| 28 | MAPK13 | 1.63629990 |
| 29 | MAP3K12 | 1.61434329 |
| 30 | BLK | 1.59438277 |
| 31 | SIK1 | 1.56079091 |
| 32 | RIPK4 | 1.46541846 |
| 33 | SGK494 | 1.46446295 |
| 34 | SGK223 | 1.46446295 |
| 35 | EPHA3 | 1.43459279 |
| 36 | GRK6 | 1.40648685 |
| 37 | CDK5 | 1.40316595 |
| 38 | CAMKK2 | 1.38948706 |
| 39 | MAP2K4 | 1.38225185 |
| 40 | SGK2 | 1.37475478 |
| 41 | TAOK2 | 1.36339395 |
| 42 | UHMK1 | 1.36091817 |
| 43 | MAP3K13 | 1.33903280 |
| 44 | DAPK1 | 1.31434704 |
| 45 | IRAK3 | 1.30672077 |
| 46 | CAMKK1 | 1.30151447 |
| 47 | ZAP70 | 1.26651309 |
| 48 | PIM2 | 1.25742170 |
| 49 | TYK2 | 1.25408043 |
| 50 | KSR1 | 1.19982443 |
| 51 | FGFR4 | 1.18164722 |
| 52 | ARAF | 1.17711776 |
| 53 | CDK19 | 1.17638313 |
| 54 | AKT3 | 1.17097044 |
| 55 | TBK1 | 1.14269661 |
| 56 | KSR2 | 1.12949484 |
| 57 | SGK3 | 1.11397064 |
| 58 | SIK3 | 1.11028496 |
| 59 | CAMK1G | 1.10551840 |
| 60 | PRKCH | 1.07751190 |
| 61 | PNCK | 1.06570228 |
| 62 | CSNK1G2 | 1.05987907 |
| 63 | IRAK2 | 1.04903994 |
| 64 | MAP3K2 | 1.04710807 |
| 65 | RPS6KA2 | 1.04672104 |
| 66 | PRKD2 | 1.02826877 |
| 67 | CSK | 1.02023944 |
| 68 | CAMK1 | 1.00376161 |
| 69 | PRKD3 | 0.97649952 |
| 70 | MAP3K3 | 0.96991983 |
| 71 | OXSR1 | 0.96593080 |
| 72 | TESK1 | 0.96315676 |
| 73 | TNK2 | 0.95594083 |
| 74 | DYRK1B | 0.95206854 |
| 75 | MARK2 | 0.93066570 |
| 76 | JAK2 | 0.92390484 |
| 77 | IKBKE | 0.91142512 |
| 78 | GRK5 | 0.90130453 |
| 79 | BTK | 0.89207105 |
| 80 | RET | 0.87472433 |
| 81 | CSNK1A1L | 0.87166968 |
| 82 | PRKCG | 0.86041241 |
| 83 | CDK12 | 0.85276584 |
| 84 | HCK | 0.82572362 |
| 85 | MAP3K1 | 0.80591918 |
| 86 | JAK3 | 0.79315022 |
| 87 | CSNK1G3 | 0.77880144 |
| 88 | LMTK2 | 0.77691336 |
| 89 | FER | 0.77572724 |
| 90 | MAPK12 | 0.77036372 |
| 91 | MAP3K5 | 0.75947288 |
| 92 | EPHB1 | 0.75657129 |
| 93 | PHKG2 | 0.73521688 |
| 94 | PHKG1 | 0.73521688 |
| 95 | CDC42BPA | 0.73328125 |
| 96 | CAMK2B | 0.73202901 |
| 97 | SGK1 | 0.72476153 |
| 98 | PKN2 | 0.72209908 |
| 99 | CAMK2A | 0.70659389 |
| 100 | PAK3 | 0.68057164 |
| 101 | PRKCE | 0.68038676 |
| 102 | MAP2K6 | 0.67376565 |
| 103 | WNK1 | 0.66928551 |
| 104 | HIPK2 | 0.66017607 |
| 105 | STK11 | 0.65316043 |
| 106 | PTK6 | 0.65283773 |
| 107 | DYRK1A | 0.63957626 |
| 108 | CCNB1 | 0.63532331 |
| 109 | MATK | 0.63018891 |
| 110 | WNK3 | 0.62657544 |
| 111 | STK38 | 0.62089001 |
| 112 | PLK2 | 0.61195807 |
| 113 | CDK18 | 0.60797467 |
| 114 | TYRO3 | 0.60331668 |
| 115 | FGFR3 | 0.57609590 |
| 116 | CDK15 | 0.56333518 |
| 117 | FGR | 0.55664732 |
| 118 | MAP3K7 | 0.54956803 |
| 119 | BRD4 | 0.52936775 |
| 120 | LYN | 0.52865908 |
| 121 | FYN | 0.52856306 |
| 122 | MAP3K14 | 0.52247045 |
| 123 | CAMK2G | 0.52116139 |
| 124 | JAK1 | 0.50719395 |
| 125 | EEF2K | 0.50602032 |
| 126 | LCK | 0.50371575 |
| 127 | ITK | 0.50232765 |
| 128 | CAMK2D | 0.49680131 |
| 129 | NEK6 | 0.49253236 |
| 130 | PDK1 | 0.48097667 |
| 131 | CDK11A | 0.47771238 |
| 132 | CDK14 | 0.46892190 |
| 133 | RAF1 | 0.44726226 |
| 134 | ERBB3 | 0.42314087 |
| 135 | MAPK11 | 0.42249968 |
| 136 | IKBKB | 0.41961870 |
| 137 | PDPK1 | 0.41198585 |
| 138 | CAMK4 | 0.41169629 |
| 139 | RPS6KL1 | 0.41023516 |
| 140 | RPS6KC1 | 0.41023516 |
| 141 | MAPK4 | 0.40785702 |
| 142 | INSRR | 0.40444772 |
| 143 | RPS6KB1 | 0.39921207 |
| 144 | RIPK1 | 0.38736419 |
| 145 | RPS6KA3 | 0.38592469 |
| 146 | ALK | 0.38088912 |
| 147 | MAPK15 | 0.37687074 |
| 148 | SYK | 0.37460162 |
| 149 | PRKCZ | 0.37017201 |
| 150 | MAPK8 | 0.36793855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.35522484 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.95036105 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.93624579 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.45585104 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.41596982 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.41243746 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.33370163 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.23560200 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.19922182 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17279544 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13999799 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.11897890 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.99054228 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97177160 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.95756795 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.87736258 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.83840234 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82901386 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78497627 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.71748072 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66149562 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.64175817 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.61854219 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59492333 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.59149201 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57217626 |
| 27 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.55558672 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53739944 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.52515422 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52380619 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.49584286 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.44597239 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40367985 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.39374455 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37064494 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.32010403 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31410578 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27989135 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27699318 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.25336008 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24335163 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22297437 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18482746 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17707905 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.17155448 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15893716 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.15520606 |
| 48 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.14726127 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14496150 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.14280838 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13702392 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11889854 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11808959 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11338814 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10924283 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 1.09412399 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 1.07570317 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05951794 |
| 59 | Gap junction_Homo sapiens_hsa04540 | 1.05681219 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04597400 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02127930 |
| 62 | Glioma_Homo sapiens_hsa05214 | 1.01427031 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99419959 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.96231331 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95702159 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93990608 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93716075 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93695186 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92836758 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92546024 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89732935 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89410666 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88020260 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.87931988 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87000676 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.85326623 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84712268 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84381070 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81702629 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80211309 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79575671 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79354991 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79249025 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79155533 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78242626 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78038980 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77838887 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.76410065 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76067497 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.74409815 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.74122434 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73637489 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73533411 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.72216371 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71529776 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.71401504 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71125348 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.70302944 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70181274 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69832867 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67957773 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67917719 |
| 103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67337147 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66801604 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65606678 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65356251 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63332919 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.62862172 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62845601 |
| 110 | * Endocytosis_Homo sapiens_hsa04144 | 0.61069976 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60916994 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.60389612 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59921291 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59642586 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59462336 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59301869 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58708476 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58580966 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57632974 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56197204 |
| 121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55302602 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55278424 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52443517 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52215076 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51761439 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51171393 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.49964599 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49927844 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49686009 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49538362 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47699405 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47450187 |
| 133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47088609 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47029849 |
| 135 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46261500 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45174851 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.44758723 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41183675 |
| 139 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40354704 |
| 140 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40336283 |
| 141 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39494610 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39326724 |
| 143 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37819551 |
| 144 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35715650 |
| 145 | Alcoholism_Homo sapiens_hsa05034 | 0.33517388 |
| 146 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33360699 |
| 147 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33312072 |
| 148 | Tuberculosis_Homo sapiens_hsa05152 | 0.33283279 |

